NAMS vs PHARM: Side-by-Side Comparison
Compare NewAmsterdam Pharma Company NV (NAMS) and Pharming Group NV (PHARM) side by side: market cap USD 4.07B vs EUR 829.85M. Financials, growth and model signals on Bullrun.
| Metric | NAMS | PHARM |
|---|---|---|
| Company | NewAmsterdam Pharma Company NV | Pharming Group NV |
| Country / Exchange | Netherlands · NASDAQ | Netherlands · AS |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 4.07B | EUR 829.85M |
| P/E ratio | — | 83.0 |
| Dividend yield | — | — |
| Valuation model | — | 48.1% overvalued |
| Revenue (FY2025) | USD 22.50M | USD 376.13M |
| Revenue growth YoY | -50.6% | +26.6% |
| Net income | USD -203.00M | USD 2.54M |
| Gross margin | — | 87.9% |
| Diluted EPS | -1.72 | 0.00 |